These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2123075

  • 1. Effects of encainide and metabolizer phenotype on ventricular conduction during exercise.
    Karalis DG, Nydegger C, Porter RS, Carver J, Pina IL, Kutalek SP, Michelson EL.
    Am J Cardiol; 1990 Dec 01; 66(19):1393-6. PubMed ID: 2123075
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of frequent ventricular arrhythmia with encainide: assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests, and radionuclide cineangiographic studies.
    DiBianco R, Fletcher RD, Cohen AI, Gottdiener JS, Singh SN, Katz RJ, Bates HR, Sauerbrunn B.
    Circulation; 1982 Jun 01; 65(6):1134-47. PubMed ID: 6804110
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study.
    Caron JF, Libersa CC, Kher AR, Kacet S, Wanszelbaum H, Dupuis BA, Poirier JM, Lekieffre JP.
    J Am Coll Cardiol; 1985 Jun 01; 5(6):1457-63. PubMed ID: 2582017
    [Abstract] [Full Text] [Related]

  • 6. Response to encainide of refractory ventricular tachycardia: clinical application of assays for parent drug and metabolites.
    Anderson JL, Stewart JR, Johnson TA, Lutz JR, Pitt B.
    J Cardiovasc Pharmacol; 1982 Jun 01; 4(5):812-9. PubMed ID: 6182414
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainide.
    Winkle RA, Peters F, Kates RE, Harrison DC.
    Am J Cardiol; 1983 Apr 01; 51(7):1182-8. PubMed ID: 6404150
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Encainide for cardiac arrhythmias.
    Med Lett Drugs Ther; 1987 May 22; 29(740):50-2. PubMed ID: 2437434
    [No Abstract] [Full Text] [Related]

  • 11. Hemodynamic effects of encainide in patients with ventricular arrhythmia and poor ventricular function.
    Sami MH, Derbekyan VA, Lisbona R.
    Am J Cardiol; 1983 Sep 01; 52(5):507-11. PubMed ID: 6412535
    [Abstract] [Full Text] [Related]

  • 12. Long-term efficacy of oral encainide in frequent and repetitive ventricular arrhythmias.
    Bongiorni MG, Levorato D, Arlotta C, Paperini L, Contini C.
    Eur Heart J; 1988 Jul 01; 9(7):765-76. PubMed ID: 3139413
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A symposium: Encainide. January 24-25, 1986, Phoenix, Arizona.
    Am J Cardiol; 1986 Aug 29; 58(5):1C-116C. PubMed ID: 3092613
    [No Abstract] [Full Text] [Related]

  • 17. [Rational treatment of heart rhythm disorders. International symposium on "The Management of Cardiac Arrhythmias: the Role of Encainide and Sotalol". 24-25 March 1988, Wallingford (USA)].
    Fortschr Med Suppl; 1988 Aug 29; 43():1-22. PubMed ID: 2898424
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.